By Professor John Allan Eisman

Journal articles

Sambrook PN; Eisman JA; Furler SM; Pocock NA, 1987, 'Computer modeling and analysis of cross‐sectional bone density studies with respect to age and the menopause', Journal of Bone and Mineral Research, 2, pp. 109 - 114, http://dx.doi.org/10.1002/jbmr.5650020205

Sambrook PN; Eisman JA; Champion GD; Yeates MG; Pocock NA; Eberl S, 1987, 'Determinants of axial bone loss in rheumatoid arthritis', Arthritis Rheumatism, 30, pp. 721 - 728, http://dx.doi.org/10.1002/art.1780300701

Pocock NA; Eberl S; Eisman JA; Yeates MG; Sambrook PN; Freund J; Duncan A, 1987, 'Dual-photon bone densitometry in normal Australian women: A cross-sectional study', Medical Journal of Australia, 146, pp. 293 - 297, http://dx.doi.org/10.5694/j.1326-5377.1987.tb120264.x

Pocock NA; Eisman JA; Hopper JL; Yeates MG; Sambrook PN; Eberl S, 1987, 'Genetic determinants of bone mass in adults: A twin study', Journal of Clinical Investigation, 80, pp. 706 - 710, http://dx.doi.org/10.1172/JCI113125

Pocock NA; Eisman JA; Dunstan CR; Evans RA; Thomas DH; Huq NL, 1987, 'Recovery from steroid-induced osteoporosis', Annals of Internal Medicine, 107, pp. 319 - 323, http://dx.doi.org/10.7326/0003-4819-107-2-319

EISMAN JA; BARKLA DH; TUTTON PJM, 1986, '1,25-DIHYDROXYVITAMIN-D3 SUPPRESSES GROWTH OF HUMAN CANCER CELL XENOGRAFTS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16, pp. 153 - 153, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986A500500144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

SAMBROOK PN; CHAMPION GD; EISMAN JA; POCOCK N; EBERL S; YEATES M, 1986, 'DOES RHEUMATOID-ARTHRITIS ACCELERATE GENERALIZED OSTEOPOROSIS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16, pp. 143 - 143, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986A500500113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

EISMAN JA, 1986, 'RAPID TURNOVER OF 1,25-DIHYDROXYVITAMIN-D RECEPTOR IN HUMAN TARGET-CELLS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16, pp. 166 - 166, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986A500500186&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

POCOCK N; EISMAN J; SAMBROOK P; YEATES M; EBERL S, 1986, 'SCREENING FOR VERTEBRAL OSTEOPENIA - THE CORRELATION BETWEEN VERTEBRAL AND FOREARM DENSITOMETRY', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16, pp. 176 - 176, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986A500500225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Eisman JA; Frampton RJ; McLean FJ, 1986, 'Biochemical significance of enhanced activity of fluorinated 1,25‐dihydroxyvitamin D3 in human cultured cell lines', Cell Biochemistry and Function, 4, pp. 115 - 122, http://dx.doi.org/10.1002/cbf.290040207

Pocock NA; Eisman JA; Yeates MG; Sambrook PN; Eberl S; Wren BG, 1986, 'Limitations of forearm bone densitometry as an index of vertebral or femoral neck osteopenia', Journal of Bone and Mineral Research, 1, pp. 369 - 375, http://dx.doi.org/10.1002/jbmr.5650010410

Eisman JA, 1986, 'Long term corticosteroid therapy: Managing side effects', Current Therapeutics, 27, pp. 41 - 46

Eisman JA; Martin TJ, 1986, 'Osteolytic Paget's disease. Recognition and risks of biopsy', Journal of Bone and Joint Surgery Series A, 68, pp. 112 - 117, http://dx.doi.org/10.2106/00004623-198668010-00014

Sambrook PN; Eisman JA; Yeates MG; Pocock NA; Eberl S; Champion GD, 1986, 'Osteoporosis in rheumatoid arthritis: Safety of low dose corticosteroids', Annals of the Rheumatic Diseases, 45, pp. 950 - 953, http://dx.doi.org/10.1136/ard.45.11.950

Pocock NA; Eisman JA; Yeates MG; Sambrook PN; Eberl S, 1986, 'Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density', Journal of Clinical Investigation, 78, pp. 618 - 621, http://dx.doi.org/10.1172/JCI112618

Eisman JA; Suva LJ; Martin TJ, 1986, 'Significance of 1, 25-Dihydroxyvitamin D 3 Receptor in Primary Breast Cancers', Cancer Research, 46, pp. 5406 - 5408

Eisman JA; Tutton PJM, 1986, 'Suppression of in Vivo Growth of Human Cancer Solid Tumor Xenografts by 1, 25-Dihydroxyvitamin D3', Cancer Research, 47, pp. 21 - 25

EISMAN JA; MARTIN TJ, 1986, 'OSTEOLYTIC PAGETS-DISEASE - RECOGNITION AND RISKS OF BIOPSY', JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 68A, pp. 112 - 117, http://dx.doi.org/10.2106/00004623-198668010-00014

Sher E; Martin TJ; Eisman JA, 1985, 'Hormone-dependent transformation and nuclear localisation of 1,25-dihydroxyvitamin D3 receptors from human breast cancer cell lines and chick duodenum', Hormone and Metabolic Research, 17, pp. 147 - 151, http://dx.doi.org/10.1055/s-2007-1013475

Eisman JA; Suva LJ; Frampton RJ, 1984, '1,25‐DIHYDROXYVITAMIN D3 AND BREAST CANCER', Australian and New Zealand Journal of Surgery, 54, pp. 17 - 20, http://dx.doi.org/10.1111/j.1445-2197.1984.tb06678.x

Eisman JA; Sher E; Suva LJ; Frampton RJ; McLean FL, 1984, '1α,25-Dihydroxyvitamin D3 specifically induces its own metabolism in a human cancer cell line', Endocrinology, 114, pp. 1225 - 1231, http://dx.doi.org/10.1210/endo-114-4-1225

Freake HC; Spanos E; Eisman JA; Galasko CSB; Martin TJ; MacIntyre I, 1984, 'Specific binding of 1,25 dihydroxyvitamin D3 in lymphocytes', Metabolism: Clinical and Experimental, 33, pp. 240 - 243, http://dx.doi.org/10.1016/S0006-291X(80)80036-2

EISMAN JA; SHER E; SUVA LJ; FRAMPTON RJ; MCLEAN FL, 1984, '1-ALPHA,25-DIHYDROXYVITAMIN-D3 SPECIFICALLY INDUCES ITS OWN METABOLISM IN A HUMAN CANCER CELL-LINE', ENDOCRINOLOGY, 114, pp. 1225 - 1231, http://dx.doi.org/10.1210/endo-114-4-1225

Frampton RJ; Omond SA; Eisman JA, 1983, 'Inhibition of Human Cancer Cell Growth by 1,25-Dihydroxyvitamin D3 Metabolites', Cancer Research, 43, pp. 4443 - 4447

EISMAN JA; FRAMPTON RJ; OMOND SA, 1983, '1,25-DIHYDROXYVITAMIN D3 METABOLITES AND ANALOGS - POTENTIAL HORMONAL INHIBITORS OF HUMAN CANCER', CALCIFIED TISSUE INTERNATIONAL, 35, pp. 692 - 692, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RA53800263&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

PRINCE RL; WARK JD; OMOND S; OPIE JM; EISMAN JA, 1983, 'A TEST OF 1,25‐DIHYDROXYVITAMIN D3 SECRETORY CAPACITY IN NORMAL SUBJECTS FOR APPLICATION IN METABOLIC BONE DISEASES', Clinical Endocrinology, 18, pp. 127 - 133, http://dx.doi.org/10.1111/j.1365-2265.1983.tb03194.x

PRINCE RL; EISMAN JA; SIMPSON RW, 1983, 'CALCIUM REGULATORY HORMONES IN IMMOBILIZATION HYPERCALCEMIA ASSOCIATED WITH RENAL-FAILURE', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 465 - 466, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RB75800074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

FRAMPTON RJ; OMOND S; EISMAN JA, 1983, 'EFFECTS OF 1,25-DIHYDROXYVITAMIN-D3 ON CULTURED HUMAN CANCER-CELLS', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 439 - 439, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RB75800029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

PRINCE RL; EISMAN JA; SIMPSON RW, 1983, 'HYPERCALCAEMIA IN ASSOCIATION WITH RENAL FAILURE: THE ROLE OF IMMOBILISATION', Australian and New Zealand Journal of Medicine, 13, pp. 8 - 10, http://dx.doi.org/10.1111/j.1445-5994.1983.tb04537.x

Prince RL; Wark JD; Eisman JA; Danks JA; Larkins RG, 1983, 'Opposing effects of cyclic adenosine-3',5'-monophosphate and cyclic guanosine-3',5'-monophosphate on the metabolism of 25-hydroxyvitamin D3 in isolated chick renal tubules', Hormone and Metabolic Research, 15, pp. 399 - 403, http://dx.doi.org/10.1055/s-2007-1018734

Gray TK; McAdoo T; Eisman J, 1983, 'Radioimmunoassay for 1,25-dihydroxycholecalciferol', Clinical Chemistry, 29, pp. 196 - 200, http://dx.doi.org/10.1093/clinchem/29.1.196

Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moseley JM; Martin TJ; Moore GE, 1982, 'Presence of 1,25-Dihydroxyvitamin D3 Receptors in Established Human Cancer Cell Lines in Culture', Cancer Research, 42, pp. 1116 - 1119

SUVA LJ; FRAMPTON RJ; OMOND S; EISMAN JA; MARTIN TJ, 1982, '1,25-(OH)2DIHYDROXYVITAMIN-D3 RECEPTORS IN PRIMARY AND CULTURED HUMAN CANCER-CELLS', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 9, pp. 575 - 576, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PK23600115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

UNDERWOOD JCE; SHER E; REED M; EISMAN JA; MARTIN TJ, 1982, 'BIOCHEMICAL APPRAISAL OF LIGAND-ANTIBODY AND LABELED-LIGAND METHODS FOR THE HISTOLOGICAL LOCALIZATION OF ESTROGEN-RECEPTORS', JOURNAL OF PATHOLOGY, 137, pp. 61 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982NR81600025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Underwood JCE; Sher E; Reed M; Eisman JA; Martin TJ, 1982, 'Biochemical assessment of histochemical methods for oestrogen receptor localisation', Journal of Clinical Pathology, 35, pp. 401 - 406, http://dx.doi.org/10.1136/jcp.35.4.401

Frampton RJ; Osmond S; Eisman JA; Martin TJ, 1982, 'Inhibition of growth in a cultured human breast cancer cell (T47 D) by 1,25 dihydroxyvitamin D', Clinical and Experimental Pharmacology and Physiology, 9, pp. No.108

Eisman JA; Frampton RJ; Suva LJ, 1982, 'Interaction of insulin and dibutyryl cyclic on 1,25-(OH)2D3 inhibition of breast cancer cell growth', Calcified Tissue International, 34, pp. S50

Sher E; Eisman JA; Martin TJ, 1982, 'Metabolism of 1,25-(OH)2D3 by the breast cancer cell line (T47 D)', Clinical and Experimental Pharmacology and Physiology, 9, pp. No.112

Eisman JA; Suva LJ; Sher E; Martin TJ, 1981, 'Frequency of 1,25-Dihydroxyvitamin D3 Receptor in Human Breast Cancer', Cancer Research, 41, pp. 5121 - 5124

Sher E; Eisman JA; Moseley JM; Martin TJ, 1981, '1,25 Dihydroxyvitamin D3 uptake and nuclear localisation in breast cancer cells (T 47D) in culture', Calcified Tissue International, 33, pp. 343

Eisman JA, 1981, '1,25-Dihydroxyvitamin D3 receptors in breast cancer', Proceedings of the Endocrine Society of Australia, Vol. 24, pp. S2

Suva LJ; Frampton RJ; Eisman JA; Martin TJ, 1981, 'Frequency of 1,25-dihydroxy vitamin D3 receptor in human breast cancer', Clinical and Experimental Pharmacology and Physiology, 8, pp. 357 - 358

Trechsel U; Taylor CM; Eisman JA; Bonjour JP; Fleisch H, 1981, 'Plasma levels of vitamin D metabolites in diphosphonate-treated rats', Clinical Science, 61, pp. 471 - 476, http://dx.doi.org/10.1042/cs0610471

Frampton RJ; Suva LJ; Eisman JA, 1981, 'Presence of 1,25-dihydroxyvitamin D3 receptors in cancer cells in culture', Proceedings of the Endocrine Society of Australia, Vol. 24, pp. 12

Wark JD; Larkins RG; Eisman JA; Wilson KR, 1981, 'Regulation of 25-hydroxy-vitamin D-1-hydroxylase in chick isolated renal tubules: Effects of prostaglandin E2, frusemide and acetylsalicylic acid', Clinical Science, 61, pp. 53 - 59, http://dx.doi.org/10.1042/cs0610053

FRAMPTON RJ; SHER E; MOSELEY JM; EISMAN JA; MARTIN TJ, 1981, 'UBIQUITY OF 1,25-DIHYDROXY VITAMIN-D3 RECEPTOR IN HUMAN-BREAST CANCER-CELLS IN CULTURE', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 8, pp. 358 - 358, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1981MQ87400015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sher E; Frampton RJ; Moseley JM; Eisman JA, 1981, 'Uptake of 3H-1,25-dihydroxy vitamin D by cultured breast cancer cells', Clinical and Experimental Pharmacology and Physiology, 8, pp. 357

Sher E; Eisman JA; Moseley JM; Martin TJ, 1981, 'Whole-cell uptake and nuclear localization of 1,25-dihydroxycholecalciferol by breast cancer cells (T47 D) in culture', Biochemical Journal, 200, pp. 315 - 320, http://dx.doi.org/10.1042/bj2000315

Eisman JA; Suva LJ; Sher E; Pearce PJ; Funder JW; Martin TJ, 1981, 'Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer.', Cancer Res, 41, pp. 5121 - 5124, https://www.ncbi.nlm.nih.gov/pubmed/6272989

Findlay DM; Micneiangell VP; Eisman JA; Framptor RJ; Moseley JM; Lain M; Martin J; Whitehead R, 1980, 'Calcitonin and 1,25-Dihydroxyvitamin D3 Receptors in Human Breast Cancer Cell Lines', Cancer Research, 40, pp. 4764 - 4767

Back to profile page